# Intravenous Chelators in Lead-Burdened Type 2 Diabetic Nephropathy

> **NCT07706946** · NA · NOT_YET_RECRUITING · sponsor: **The Fourth Affiliated Hospital of Zhejiang University School of Medicine** · enrollment: 42 (estimated)

## Conditions studied

- Lead-Burdened Type 2 Diabetic Nephropathy

## Interventions

- **DRUG:** chelator

## Key facts

- **NCT ID:** NCT07706946
- **Lead sponsor:** The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2029-01-01
- **Final completion:** 2029-01-01
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2026-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07706946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07706946, "Intravenous Chelators in Lead-Burdened Type 2 Diabetic Nephropathy". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07706946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*